BD Biosciences
Genomics, proteomics, antibodies and reagents, drug discovery, oncology, immune function, etc.
BD is a medical technology company founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897. BD Biosciences is a segment of Becton, Dickinson and Company.
Edward J. Ludwig (CEO)
John R. Considine (CFO)
Scott P. Bruder (CTO)
Edward J. Ludwig (Chairman)
Basil L. Anderson
Gary A. Mecklenburg
Henry P. Becton, Jr.
James F. Orr
Edward F. DeGraan
Willard J. Overlock, Jr.
Claire M. Fraser-Liggett
Cathy E. Minehan
Marshall O. Larsen (effective 9/24/07)
Bertram L. Scott
Alfred Sommer
Adel A.F. Mahmoud
BD Biosciences
2350 Qume Drive
San Jose, CA 95131
USA
Phone: +1-877-232-8995
Related news
- BD Announces Results for Second Quarter Fiscal 2010
- BD Completes Acquisition of HandyLab, Inc.
- BD Announces Results for Fourth Fiscal Quarter and Full Year
- BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
- BD Announces CE Marking of the BD GeneOhm(TM) VanR Molecular Test for the Rapid Detection of Vancomycin Resistance
